NCT05656833 - Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser for Treatment of Facial Melasma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

July 31, 2023

Conditions

Melasma

Interventions

DEVICE

Fractional 1927nm Low-Powered Diode Laser

Clear \& Brilliant Permea® Laser used on the side of the face randomized to receive laser

OTHER

Topical Cysteamine

Topical Cysteamine cream will be used on the entire face.

Trial Locations (1)

RECRUITING

UnionDerm, New York